Furthermore, miR-101 reduced m6A enrichment on EIF3J-AS1 by suppressing METTL3, thereby disrupting FOXG1–EIF3J-AS1 binding and inducing MIF expression, leading to autophagy activation and glioma suppression. The gene discussed is METTL3; the disease is glioma.